Hepatic Failure
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment (NCT04587622) | Novartis Pharmaceuticals | 2020-10-30 |
| Pyrophosphate Homeostasis and Hepatic Expression of ABCC6.Pyro-TH (NCT03576859) | Centre Hospitalier Universitaire de Nice | 2018-11-06 |
| The Plasma Diafiltration Therapy of Hepatic Failure (NCT03560414) | Fuzhou General Hospital | 2018-06-01 |
| An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function (NCT03515980) | Bristol-Myers Squibb | 2018-05-25 |
| Cardiox Liver Function Test Pivotal Trial (NCT02552901) | Cardiox Corporation | 2015-11-01 |
| Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects (NCT01846455) | Indivior Inc. | 2012-09-01 |
| Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function (NCT00831532) | Pfizer | 2009-02-01 |
Track Hepatic Failure automatically
Every clearance here is in the API, with alerts when new ones post.